Let's try not to swing the pendulum too far in the other direction—risking another form of high mortality. Instead, let's aim to find the sweet spot. I am Inneke De laet , Intensivist from ZNA in ANtwerep, Belgium. My lecture focused on de-resuscitation in the critically ill—and whether this could be the key to solving the problem of fluid overload. As we've seen, aggressive fluid administration may save lives in the early phases of shock, but excess fluids later on can be harmful, and managing this balance is critical to improving outcomes. One of the great strengths of the IFAD Congress is that, unlike broader ICU meetings where a wide range of topics are only briefly touched on, here we can focus deeply on one essential area: fluid therapy. This narrow focus allows for in-depth presentations, richer discussions, and more meaningful exchanges between experts. I believe it's also important to highlight the value of collegial interaction at meetings like this. While randomized controlled trials (RCTs) remain essential, we are increasingly recognizing the importance of understanding how to translate those results into clinical practice. And that's something you can only refine by sharing real-world experiences and perspectives with your peers. This congress provides exactly that kind of environment—specialized, collaborative, and clinically relevant.

Ver todos los episodios